Wareth Gamal, Brandt Christian, Sprague Lisa D, Neubauer Heinrich, Pletz Mathias W
Friedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Naumburger Str. 96a, 07743 Jena, Germany.
Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, Egypt.
Microorganisms. 2020 Mar 6;8(3):375. doi: 10.3390/microorganisms8030375.
() has gained global notoriety as a significant nosocomial pathogen because it is frequently associated with multi-drug resistance and hospital-based outbreaks. There is a substantial difference in the incidence of infections between different countries and within Germany. However, its continuous spread within Germany is a matter of concern. A systematic literature search and analysis of the literature published between 2000 and 2018 on in humans was performed. Forty-four studies out of 216 articles met the criteria for inclusion, and were selected and reviewed. The number of published articles is increasing over time gradually. Case reports and outbreak investigations are representing the main body of publications. North Rhine-Westphalia, Hesse and Baden-Wuerttemberg were states with frequent reports. Hospitals in Cologne and Frankfurt were often mentioned as specialized institutions. Multiresistant strains carrying diverse resistance genes were isolated in 13 of the 16 German states. The oxacillinase OXA-23-like, intrinsic OXA-51-like, OXA-58 variant, NDM-1, GES-11, CTX-M and TEM are the most predominant resistance traits found in German annii isolates. Five clonal lineages IC-2, IC-7, IC-1, IC-4 and IC-6 and six sequence types ST22, ST53, ST195, ST218, ST944/ST78 and ST348/ST2 have been reported. Due to multidrug resistance, colistin, tigecycline, aminoglycosides, fosfomycin, ceftazidime/avibactam and ceftolozan/tazobactam were often reported to be the only effective antibiotics left to treat quadruple multi-resistant Gram-negative (4MRGN) Dissemination and infection rates of are on the rise nationwide. Hence, several aspects of resistance development and pathogenesis are not fully understood yet. Increased awareness, extensive study of mechanisms of resistance and development of alternative strategies for treatment are required. One-Health genomic surveillance is needed to understand the dynamics of spread, to identify the main reservoirs and routes of transmission and to develop targeted intervention strategies.
()作为一种重要的医院病原体已在全球声名狼藉,因为它经常与多重耐药性和医院内暴发相关联。不同国家以及德国国内不同地区的感染发病率存在显著差异。然而,它在德国境内的持续传播令人担忧。我们对2000年至2018年间发表的关于人类感染的文献进行了系统的文献检索和分析。216篇文章中有44项研究符合纳入标准,并被选取和审查。发表文章的数量随时间逐渐增加。病例报告和暴发调查是出版物的主体。北莱茵 - 威斯特法伦州、黑森州和巴登 - 符腾堡州是报告频繁的州。科隆和法兰克福的医院常被提及为专业机构。在德国16个州中的13个州分离出携带多种耐药基因的多重耐药菌株。在德国分离株中发现的最主要耐药特征是奥沙西林酶OXA - 23样、固有OXA - 51样、OXA - 58变体、NDM - 1、GES - 11、CTX - M和TEM。已报道了5个克隆谱系IC - 2、IC - 7、IC - 1、IC - 4和IC - 6以及6种序列类型ST22、ST53、ST195、ST218、ST944/ST78和ST348/ST2。由于多重耐药性,黏菌素、替加环素、氨基糖苷类、磷霉素、头孢他啶/阿维巴坦和头孢洛扎/他唑巴坦常被报道为治疗四重多重耐药革兰氏阴性菌(4MRGN)仅剩的有效抗生素。在全国范围内的传播和感染率正在上升。因此,耐药性发展和发病机制的几个方面尚未完全了解。需要提高认识,广泛研究耐药机制并制定替代治疗策略。需要开展“同一健康”基因组监测来了解传播动态,确定主要储存宿主和传播途径,并制定有针对性的干预策略。